Published in Health and Medicine Week, April 20th, 2006
"Towne CMV vaccine is safe and immunogenic, though its protective efficacy has yet to be optimized. We describe antigen-specific T cell responses to Towne vaccination," wrote M.A. Jacobson and colleagues of the University of California, San Francisco.
"Three thousand pfu Towne CMV vaccine were given to 12 CMV-seronegative volunteers. CMV-specific CD4+ and CD8+ T cell proliferation and IFN gamma expression were measured by flow cytometry after stimulation...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health and Medicine Week